ROWE COMPANIES·4

Jul 8, 2:22 PM ET

ROWE COMPANIES 4

4 · ROWE COMPANIES · Filed Jul 8, 2005

Insider Transaction Report

Form 4
Period: 2005-07-07
MORPHIS GENE S
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2005-07-07$3.80/sh+2,500$9,50035,500 total
  • Purchase

    Common Stock

    2005-07-07$3.84/sh+600$2,30436,100 total
  • Purchase

    Common Stock

    2005-07-08$3.90/sh+100$39036,200 total
Holdings
  • Option to purchase

    Exercise: $2.15From: 2005-06-03Exp: 2012-12-03common (1,333 underlying)
    8,000
  • Option to purchase

    Exercise: $1.95From: 2004-07-30Exp: 2012-07-30common (5,000 underlying)
    13,000
  • Common Stock

    33,000
  • Option to purchase

    Exercise: $2.15From: 2004-12-03Exp: 2012-12-03common (1,333 underlying)
    6,667
  • Option to Purchase

    Exercise: $3.96From: 2005-04-07Exp: 2015-04-07common (15,000 underlying)
    40,000
  • Option to purchase

    Exercise: $2.15From: 2003-06-03Exp: 2012-12-03common (1,334 underlying)
    2,668
  • Option to purchase

    Exercise: $2.15From: 2004-06-03Exp: 2012-12-03common (1,333 underlying)
    5,334
  • Option to purchase

    Exercise: $2.15From: 2002-12-03Exp: 2012-12-03common (1,334 underlying)
    1,334
  • Option to purchase

    Exercise: $2.15From: 2003-12-03Exp: 2012-12-03common (1,333 underlying)
    4,001
  • Option to Purchase

    Exercise: $3.00From: 2003-12-01Exp: 2013-12-01common (12,000 underlying)
    25,000

Documents

1 file
  • 4
    rrd85290.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP